203 related articles for article (PubMed ID: 17507008)
1. Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment.
Herrick-Davis K; Grinde E; Weaver BA
Eur J Pharmacol; 2007 Jul; 568(1-3):45-53. PubMed ID: 17507008
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells.
Herrick-Davis K; Grinde E; Mazurkiewicz JE
Biochemistry; 2004 Nov; 43(44):13963-71. PubMed ID: 15518545
[TBL] [Abstract][Full Text] [Related]
4. The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptors.
Millan MJ; Marin P; Kamal M; Jockers R; Chanrion B; Labasque M; Bockaert J; Mannoury la Cour C
Int J Neuropsychopharmacol; 2011 Jul; 14(6):768-83. PubMed ID: 20946699
[TBL] [Abstract][Full Text] [Related]
5. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
Herrick-Davis K; Grinde E; Niswender CM
J Neurochem; 1999 Oct; 73(4):1711-7. PubMed ID: 10501219
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.
Herrick-Davis K; Grinde E; Harrigan TJ; Mazurkiewicz JE
J Biol Chem; 2005 Dec; 280(48):40144-51. PubMed ID: 16195233
[TBL] [Abstract][Full Text] [Related]
7. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.
Farrell M; Rosenzweig-Lipson S; Walker E
Psychopharmacology (Berl); 2010 Aug; 211(2):149-59. PubMed ID: 20526585
[TBL] [Abstract][Full Text] [Related]
10. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
[TBL] [Abstract][Full Text] [Related]
11. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
[TBL] [Abstract][Full Text] [Related]
12. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Berg KA; Cropper JD; Niswender CM; Sanders-Bush E; Emeson RB; Clarke WP
Br J Pharmacol; 2001 Sep; 134(2):386-92. PubMed ID: 11564657
[TBL] [Abstract][Full Text] [Related]
13. A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling.
Berg KA; Dunlop J; Sanchez T; Silva M; Clarke WP
J Pharmacol Exp Ther; 2008 Mar; 324(3):1084-92. PubMed ID: 18065501
[TBL] [Abstract][Full Text] [Related]
14. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
[TBL] [Abstract][Full Text] [Related]
15. Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors.
Mombereau C; Kawahara Y; Gundersen BB; Nishikura K; Blendy JA
Neuropharmacology; 2010 Nov; 59(6):468-73. PubMed ID: 20624407
[TBL] [Abstract][Full Text] [Related]
16. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass.
Kawahara Y; Grimberg A; Teegarden S; Mombereau C; Liu S; Bale TL; Blendy JA; Nishikura K
J Neurosci; 2008 Nov; 28(48):12834-44. PubMed ID: 19036977
[TBL] [Abstract][Full Text] [Related]
18. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
19. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
Andressen KW; Manfra O; Brevik CH; Ulsund AH; Vanhoenacker P; Levy FO; Krobert KA
Br J Pharmacol; 2015 Aug; 172(15):3846-60. PubMed ID: 25884989
[TBL] [Abstract][Full Text] [Related]
20. Impact of RNA editing on functions of the serotonin 2C receptor in vivo.
Olaghere da Silva UB; Morabito MV; Canal CE; Airey DC; Emeson RB; Sanders-Bush E
Front Neurosci; 2010; 4():26. PubMed ID: 20582266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
